RESULTS:
A total of 66 consecutive patients were included with 6 patients undergoing primary closure of the abdomen as the control group. Twenty patients underwent closure with polypropylene mesh and 40 patients had resorbable monofilament poly-4-hydroxybutyrate mesh (Phasix, Bard Davol Inc.) placement. There were no significant differences in patient demographics, comorbidities, or cancer treatment between the three groups. Early complications including wound dehiscence and seroma formation were significantly higher in the polypropylene and control groups compared to the Phasix group (20.0% vs. 16.7% vs. 0%, p<0.05 and 10.0% vs. 16.7% vs. 0%, p<0.001). Two of these patients with polypropylene mesh required operative debridement while all other patients were managed conservatively. Drain removal was also significantly faster in the resorbable mesh group compared to the polypropylene group (17.8 days vs. 21.2 days, p=0.004). Two patients with polypropylene mesh and one patient undergoing primary closure developed an abdominal bulge while no bulges or hernias were identified in the Phasix group in an average follow-up of 14.9 months (11.5% vs. 0%).
CONCLUSION:
Hernias and bulges are some of the most concerning late complications associated with breast reconstruction with abdominal-based free flaps. The use of resorbable mesh significantly reduces the risks of early complications while also minimizing the risk of developing a hernia or bulge after long term follow-up beyond one year. Although these clinical decisions may take into account the muscle mass and degree of wrinkle formation, this method is inherently subjective and operator dependent. Digital Image Speckle Correlation (DISC) is a technology that tracks pore movement from rest to maximal exertion, thus allowing for the objective determination of the optimal sites of injection. DISC also provides the ability to track the degree of paralysis following BT injection. In this prospective crossover trial, we compare the efficacy of utilizing DISC compared to physician assessment in determining BT injection sites.
METHODS: 10 female patients aged 32-59 (mean 46.8) were enrolled in our study. Subjects were randomized to one of two arms. Group I received BT injections based on DISC analysis first, and Group II received BT injections based on the 2004 "Consensus Recommendations on the Use of
